Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 0.55% | 26.83 | 14.1% | $157.87m | |
| HZNP | Horizon Therapeutics Plc | -0.27% | 77.23 | 5.6% | $151.68m | |
| ACRS | Aclaris Therapeutics, Inc. | 1.27% | 18.27 | 5.3% | $139.68m | |
| CTLT | Catalent, Inc. | -1.13% | 116.95 | 2.1% | $102.69m | |
| BHC | Bausch Health Cos., Inc. | 0.73% | 26.88 | 0.0% | $100.93m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.07% | 165.89 | 2.4% | $86.49m | |
| ACST | Acasti Pharma, Inc. | -6.39% | 0.78 | 0.2% | $81.94m | |
| ISR | IsoRay, Inc. | -3.73% | 2.32 | 2.5% | $62.17m | |
| UTHR | United Therapeutics Corp. | -0.91% | 165.62 | 14.1% | $61.46m | |
| AMRN | Amarin Corp. Plc | 2.22% | 6.45 | 1.5% | $51.55m | |
| GWPH | GW Pharmaceuticals Plc | -0.31% | 137.99 | 6.1% | $50.54m | |
| PRGO | Perrigo Co. Plc | -0.93% | 43.02 | 6.8% | $49.97m | |
| ARGX | argenx SE | -1.26% | 311.33 | 0.0% | $48.52m | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | 7.13% | 1.05 | 0.2% | $45.14m | |
| SAGE | SAGE Therapeutics, Inc. | -5.71% | 87.16 | 7.6% | $42.70m |
Company Profile
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops product candidates for the treatment of impulsive aggression and for the treatment of attention deficit hyperactivity disorder. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.